GRI Bio, Inc. (GRI)
(Delayed Data from NSDQ)
$0.77 USD
-0.02 (-2.87%)
Updated Jul 31, 2024 03:59 PM ET
After-Market: $0.75 -0.02 (-2.01%) 7:16 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
GRI 0.77 -0.02(-2.87%)
Will GRI be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for GRI based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for GRI
Galore Resources Hit by Management Trade Halt
LONDON BROKER RATINGS: Greencore and Hammerson cut to 'hold'
7 Sorry Biotech Stocks Set to Make Investors Sad
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Grainger says new UK housing proposals give "greater certainty"